Baltimore-Washington Financial Advisors’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$580K Hold
1,649
0.03% 110
2025
Q4
$540K Buy
1,649
+1
+0.1% +$317 0.02% 113
2025
Q3
$465K Buy
+1,648
New +$478K 0.02% 119
2015
Q4
Sell
-1
Closed 97
2015
Q3
$0 Buy
+1
New +$158 ﹤0.01% 268
2015
Q1
Sell
-4
Closed -$1K 301
2014
Q4
$1K Hold
4
﹤0.01% 245
2014
Q3
$1K Buy
+4
New +$522 ﹤0.01% 264
2013
Q4
Sell
-110
Closed -$12K 306
2013
Q3
$12K Sell
110
-34,140
-100% -$3.7M ﹤0.01% 174
2013
Q2
$3.38M Buy
+34,250
New +$3.55M 1.46% 30

Other funds holding AMGN

Baltimore-Washington Financial Advisors's AMGN Position: Q1 2026 in Review

Baltimore-Washington Financial Advisors held its Amgen (AMGN) position steady in Q1 2026 at 1,649 shares worth $580K. The position accounts for 0.03% of the portfolio, ranked #110.

Baltimore-Washington Financial Advisors first reported a position in AMGN in Q2 2013 and has held it in 8 quarters since. The position peaked at $3.38M in Q2 2013. 3,130 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Baltimore-Washington Financial Advisors held 1,649 shares of Amgen worth $580K as of Q1 2026.
  • Baltimore-Washington Financial Advisors left its Amgen share count unchanged in Q1 2026.
  • Amgen made up 0.03% of Baltimore-Washington Financial Advisors's portfolio in Q1 2026, its #110 holding.
  • Baltimore-Washington Financial Advisors first reported a position in Amgen in Q2 2013 and has held it in 8 quarters since.
  • Baltimore-Washington Financial Advisors's Amgen position peaked at $3.38M in Q2 2013.
  • 3,130 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Baltimore-Washington Financial Advisors's 13F filing for Q1 2026, filed 15 May 2026.